OptimizeRx Stock

OptimizeRx Short-term Debt

The Short-Term Debt of OptimizeRx (OPRX) as of Aug 23, 2026 is 4.45 M USD. In the previous year, Short-Term Debt was 2.17 M USD — a change of 105.17% (higher).

Short-term Debt

4.45 MUSD

YoY

105.17%

Last updated:

Short-Term Debt of OptimizeRx is 2026 4.45 M USD. Short-Term Debt of OptimizeRx was 2025 2.17 M USD. It decreases by 105.17% higher compared to the previous year.

The OptimizeRx Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2017
1.18 M USD
Jan 1, 2019
115,431.00 USD
Jan 1, 2020
123,220.00 USD
Jan 1, 2021
90,982.00 USD
Jan 1, 2022
89,902.00 USD
Jan 1, 2023
2.22 M USD
Jan 1, 2024
2.17 M USD
Jan 1, 2025
4.45 M USD
The OptimizeRx Short-term Debt history
YEARShort-term DebtYoY
4.45 MUSD+105.17%
2.17 MUSD-2.41%
2.22 MUSD+2,371.16%
89,902.00USD-1.19%
90,982.00USD-26.16%
123,220.00USD+6.75%
115,431.00USD-90.19%
1.18 MUSD-52.82%
2.50 MUSD+5.92%
2.36 MUSD+56.75%
1.50 MUSD—
Access this data via the Eulerpool API
Get Free API Key

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Short-Term Debt of OptimizeRx is 4.45 M USD in 2026.

Short-Term Debt of OptimizeRx changed from 2.17 M USD to 4.45 M USD, representing a 105.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt OptimizeRx since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's OptimizeRx historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — OptimizeRx

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — OptimizeRx